Huakang Biomedical Holdings Company Limited (8622.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 195.93M |
| Enterprise Value | 163.93M |
| P/E Ratio | -16.43 |
| PEG Ratio | 1.12 |
| Price/Sales Ratio | 2.99 |
| Price/Book Ratio | 1.61 |
| Enterprise/Revenue | 1.86 |
| Enterprise/EBITDA | -8.54 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.18 |
| Operating Margin | -0.3 |
AD
Management Effectiveness
| Return On Assets | -0.08 |
| Return On Equity | -0.1 |
Income Statement
| Revenue | 28.28M |
| Revenue/Share | 0.06 |
| Gross Profit | 17.77M |
| EBITDA | -6.17M |
| Net Income | -5.01M |
| Diluted EPS | -0.01 |
Balance Sheet
| Total Cash | 41.96M |
| Total Cash/Share | 0.08 |
| Total Debt | 4.96M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 3.88 |
| Book Value Per Share | 0.1 |
Price History
| 52-Week Change | -52.5 |
| 52-Week High | 0.75 |
| 52-Week Low | 0.19 |
| Moving Average 50 Days | 0.29 |
| Moving Average 200 Days | 0.38 |
Statistics
| Average Volume | 334,915 |
| Shares Outstanding | 515.47M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
